Up Next
Back to Show
PBS News Hour
The risks and rewards of expedited vaccine development
The race to develop vaccine candidates to prevent COVID-19 represents an unprecedented national and global effort. President Trump and some public health experts say encouraging early results from Pfizer and Moderna suggest the approach is working. But there are also questions about the risks of ramping up vaccine research and development at this scale and on this timeline. Miles O’Brien reports.
Support Provided By
57:46
Israel's Prime Minister says the intense phase of the war in Gaza will end soon as Israel and the U.S. argue over weapons deliveries.
57:46
After Claudia Sheinbaum becomes the first woman to win Mexico's presidential election, a look at what that means for U.S. relations.
26:44
"PBS NewsHour" asks NATO’s Secretary General if the delayed U.S. aid to Ukraine is too late to make a difference.
56:45
A court rejects Trump's claim of immunity with major implications for his election interference case.
26:36
Why a record number of people across America are experiencing homelessness this holiday season.
24:44
How some cities are testing no-strings-attached payment programs as a way to help lower-income residents get a leg up.
56:45
Hunter Biden's plea deal unravels over concerns about whether future charges can be brought against the president's son.
56:45
Floodwaters rage and dangerous heat waves grow worse, posing serious risks to millions of Americans.
56:44
NATO leaders kick off a multi-nation summit with Ukraine seeking a path to join the expanding alliance.